FLUIDIGM CORP Uncategorized Contracts & Agreements
74 Contracts & Agreements
- Offer letter, by and between Standard BioTools Inc. and Jeremy Davis, dated April 4, 2023 (Filed With SEC on August 8, 2023)
- Form of PSU Award Agreement (Filed With SEC on July 28, 2023)
- Offer letter by and between Standard BioTools Inc. and Jeffery G. Black executed May 10, 2023 (Filed With SEC on May 15, 2023)
- Letter agreement by and between Standard BioTools Inc. and Vikram Jog dated May 10, 2023 (Filed With SEC on May 15, 2023)
- Support Agreement, dated March 29, 2022, by and among Fluidigm Corporation and Caligan Partners LP and certain of its affiliates (Filed With SEC on March 29, 2022)
- Letter Agreement dated March 25, 2022 (Filed With SEC on March 28, 2022)
- Michael Egholm Offer Letter (Filed With SEC on January 24, 2022)
- Hanjoon Alex Kim Offer Letter (Filed With SEC on January 24, 2022)
- Amendment dated (Filed With SEC on November 9, 2021)
- Amendment dated May 10, 2021 to (Filed With SEC on August 6, 2021)
- Repatriation Agreement with Colin McCracken dated June 16, 2021 (Filed With SEC on August 6, 2021)
- Contract by and between the National Institutes of Health and the registrant effective as of July 30, 2020, as amended September 28, 2020 (Filed With SEC on May 7, 2021)
- Description of Securities (Filed With SEC on February 25, 2021)
- Offer Letter to Colin McCracken dated April 12, 2019 (Filed With SEC on February 25, 2021)
- Offer Letter to Nick Khadder dated April 6, 2020 (Filed With SEC on February 25, 2021)
- Contract by and between the National Institutes of Health and the (Filed With SEC on November 9, 2020)
- Letter Agreement between President and Fellows of Harvard College and the registrant dated December 22, 2004 (Filed With SEC on November 9, 2020)
- Open Market Sale AgreementSM, dated as of March 4, 2020, between Fluidigm Corporation and Jefferies LLC (Filed With SEC on March 5, 2020)
- Description of Securities (Filed With SEC on February 27, 2020)
- Offer Letter to Bradley A. Kreger dated February 13, 2018 (Filed With SEC on March 18, 2019)
- Offer Letter to Chris Linthwaite, dated as of July 14, 2016 (Filed With SEC on May 8, 2018)
- Endorsement Split-Dollar Life Insurance Agreement (Filed With SEC on November 7, 2017)
- FLUIDIGM CORPORATION 2017 INDUCEMENT AWARD PLAN (Filed With SEC on January 11, 2017)
- TAX BENEFIT PRESERVATION PLAN Dated as of November 21, 2016 by and between FLUIDIGM CORPORATION and COMPUTERSHAREINC., as Rights Agent TABLE OF CONTENTS (Filed With SEC on November 22, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 9, 2016)
- ascendas.com (Filed With SEC on August 10, 2015)
- SUBLICENSE AGREEMENT (Filed With SEC on May 12, 2014)
- Monthly Service Charge (Filed With SEC on March 12, 2014)
- FluidigmCorporation 7000 Shoreline Court, Suite 100, South San Francisco, California 94080 tel:650.266.6000 fax: 650.871.7152 www.fluidigm.com (Filed With SEC on April 4, 2011)
- CONFIDENTIAL TREATMENT REQUESTED BY FLUIDIGM CORPORATION LICENSEAGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: [ ] (Filed With SEC on February 2, 2011)
- COLLABORATIONAND OPTION AGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION DATE: MAY 17, 2010 (Filed With SEC on January 18, 2011)
- LICENSEAGREEMENT by and between NOVARTIS VACCINES & DIAGNOSTICS, INC. and FLUIDIGM CORPORATION Date: [ ] (Filed With SEC on January 18, 2011)
- FLUIDIGM CORPORATION and 454 LIFE SCIENCES, A ROCHE COMPANY CO-PROMOTION AGREEMENT (Filed With SEC on January 18, 2011)
- 5,300,000 SHARES (Filed With SEC on September 15, 2008)
- Shares (Filed With SEC on September 15, 2008)
- FLUIDIGM CORPORATION (Filed With SEC on September 15, 2008)
- Fluidigm Corporation a California corporation (Filed With SEC on September 15, 2008)
- MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and THE UAB RESEARCH FOUNDATION dated... (Filed With SEC on September 15, 2008)
- PROJECT MILESTONES AND DELIVERABLES (Filed With SEC on September 15, 2008)
- EXHIBIT 10.3A (Filed With SEC on September 5, 2008)